Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial (Q29619615)
scientific article (publication date: 24 July 2010)
Language:
(P31) (Q13442814)
(P50) (Q21264574)
(Q63032640)
(P304) 245-51
(P407) (Q1860)
(P433) 9737
(P478) 376
(P577) Saturday, July 24, 2010
(P921) (Q172341)
(Q7083106)
(P1433) (Q939416)
(P1476) "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial" (language: en)
(P2093) Audeh MW
Carmichael J
Penson RT
Friedlander M
Powell B
Bell-McGuinn KM
Scott C
Oaknin A
Loman N
Lu K
Matulonis U
Wickens M
Tutt A
(P2860) (Q34335821)
(Q36602569)
(Q34081887)
(Q29614844)
(Q29618799)
(Q35026396)
(Q39937374)
(Q33658723)
(Q80423982)
(Q37203855)
(Q63383833)
(Q63362916)
(Q28268061)
(Q28131711)
(Q27860519)
(Q57247907)
(Q39971672)
(Q24644255)
(Q27851474)
(Q39712677)
(Q27860904)
(Q37369575)
(Q28268169)
(Q30080035)
(Q36042091)
(Q33315604)
other details
description scientific article (publication date: 24 July 2010)

External Links